{"id":12813,"date":"2024-08-12T15:17:36","date_gmt":"2024-08-12T19:17:36","guid":{"rendered":"https:\/\/clariowebstg.wpengine.com\/?post_type=articles&p=12813"},"modified":"2025-09-29T13:35:46","modified_gmt":"2025-09-29T17:35:46","slug":"researcher-spotlight-lori-quinn","status":"publish","type":"articles","link":"https:\/\/clario.com\/resources\/articles\/researcher-spotlight-lori-quinn\/","title":{"rendered":"Researcher spotlight: Lori Quinn"},"content":{"rendered":"\n

Precision Motion<\/h2>\n\n\n\n

March 12, 2025<\/p>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n
\n\t\n\n
\n\t\t\t
\n\t\t\t\n
\n
\n
\n
\n \"\"\n <\/div>\n
\n \"\"\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n\t\t<\/div>\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

Lori Quinn, PT, EdD, FAPTA<\/h4>\n\n\n\n

Professor, Motor Learning and Control Program Department of Biobehavioral Studies, Teachers College at Columbia University<\/p>\n\n\t<\/div>\n\n<\/div>\n\n\t<\/div>\n\n\n\n

\n\t\t\t\n\n

Opal V2R\u00ae\u00a0technology has been used by thousands of researchers worldwide, and together, these researchers have published more than 750 peer reviewed papers, greatly contributing to the available body of evidence in human movement.<\/p>\n\n\n\n

APDM is a part of Clario, a leading provider of endpoint data solutions to the clinical trials industry.\u00a0For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world.<\/p>\n\n\n\n

The Opal V2R\u00ae\u00a0solution has been utilized to assess human movement across more than 30 therapeutic indications providing richer insights and meaningful outcomes. Unlock the full potential of your research with Opal V2R\u00ae technology.<\/p>\n\n\n\n

For more information, visit our Wearable Biosensors for Research page<\/a>. <\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

Would you please introduce yourself, your academic background and your research interests?<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

I am Professor in the Motor Learning and Control Program, Department of Biobehavioral Studies, at Teachers College, Columbia University. I received a BS in physical therapy from the University of Connecticut in 1989 and an Ed.D. in Movement Sciences from Teachers College in 1996. I am currently the director of the Neurorehabilitation Research Lab at Teachers College, and my research has focused on movement-based evaluations and interventions for people with neurodegenerative diseases, including people with Huntington’s disease and Parkinson\u2019s disease. My work incorporates use of wearable devices for digital-based assessments.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

Do you have a personal story that led to your interest in human movement\/ neurodegenerative disease research? What continues to drive your ambitions as a scientist?<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

I have a strong desire to develop evidence-based interventions for people with neurodegenerative diseases. Having sensitive measures of gait and mobility are critical to testing the efficacy of physical activity interventions, particularly in the early disease stages. I am also driven by my students, who ask great questions and motivate me to be a better clinical researcher.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

How has Clario’s APDM Opal V2R\u00ae System<\/a> been most useful in your research endeavors?<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

We have used Clario\u2019s APDM Opal sensors to evaluate measures of gait, mobility and postural control in individuals with Huntington\u2019s disease, stroke and Parkinson\u2019s disease. We have identified several measures of postural sway and mobility that were most sensitive as early markers of disease in people with HD.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

What research projects or questions are you currently working on?<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

We are extending on previous work in Huntington\u2019s disease on a project called Balance-HD. We are collaborating with Nora Fritz, PT, DPT, PhD Wayne State University; Lisa Muratori, Stony Brook University; and Deb Kegelmeyer and Anne Kloos, Ohio State University to validate measures of balance in individuals with Huntington\u2019s disease across disease stages using clinical measures as well as APDM Opal sensors. We hope to identify measures that can be used as clinical trial endpoints, both for physical activity and exercise interventions, as well as pharmacological and gene-based therapies. We are also using APDM sensors in a study in Parkinson\u2019s disease, evaluating functional mobility in various transitional tasks. This study is being conducted by two of my doctoral students \u2013 Jehan Alomar and Lilliana Romero.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

Where do you see the use of wearable IMU\u2019s in human movement research going in the next 5 years?<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

I believe wearable IMUs will be ubiquitous in clinical research, and importantly will help us provide sensitive measures of mobility not just in the clinic but in daily living environments. I hope we will move to more consistently evaluating individuals in their homes and communities as means to track disease progression and identify motor impairments earlier.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Q:<\/mark> <\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

Fill in the blank:<\/strong><\/mark> When I\u2019m not working on a research project, you can find me\u2026<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n

A: <\/mark><\/strong><\/h2>\n\n\t<\/div>\n\n\n\n
\n\t\t\t\n\n

Playing golf! I recently took up golf and am obsessed with mastering this skill! And enjoying time with my husband and two daughters.<\/p>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n

\n
\n \n
\n\t\n\n
\n\t\t\t\n\n

Check out some of this researcher’s recent publications<\/h2>\n\n\t<\/div>\n\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n
\n
\n Peer-Reviewed<\/span>

Measures of postural control and mobility during dual-tasking as candidate markers of instability in Huntington’s disease<\/h3>Read<\/span><\/a> <\/article>\n <\/div>\n\n\t<\/div>\n\n<\/div>\n\n <\/div>\n<\/div>\n\n\n
\n\t\n\n
\n\t\t\t\n\n
\n